General Information of Drug (ID: DMV9FLB)

Drug Name
CNSA-001
Indication
Disease Entry ICD 11 Status REF
Gastroparesis DA41.00 Phase 2 [1]
Hyperphenylalaninemia 5C50 Phase 1/2 [2]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
135398579
TTD ID
D3M7FK
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT03712124) A Study of CNSA-001 in Women With Diabetic Gastroparesis. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03519711) A Study of CNSA-001 in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia. U.S. National Institutes of Health.